Respiratory syncytial virus infections Trials in Miami, United States
Conditions / Respiratory syncytial virus infections / Miami, United States
Respiratory syncytial virus infections has been the subject of sustained clinical investigation across multiple research sites.
17 total trials for this combination
Showing top 10 of 17 trials
Trials
| NCT ID | Title | Status | Phase |
|---|---|---|---|
| NCT03379675 | A Study to Explore the Antiviral Activity, Clinical Outcomes, Safety, Tolerability, and Pharmacokinetics of JNJ-53718678 at Two Dose Levels in Non-Hospitalized Adult Participants Infected With Respiratory Syncytial Virus | COMPLETED | PHASE2 |
| NCT00384462 | Study to Evaluate the Incidence of Hospitalizations and Respiratory Tract Infections in Premature Infants | COMPLETED | — |
| NCT04886596 | Efficacy Study of GSK's Investigational Respiratory Syncytial Virus (RSV) Vaccine in Adults Aged 60 Years and Above | COMPLETED | PHASE3 |
| NCT00129766 | Study of MEDI-524 (Motavizumab) for the Prophylaxis of Serious Respiratory Syncytial Virus (RSV) Disease in High-Risk Children | COMPLETED | PHASE3 |
| NCT02325791 | Study to Evaluate the Efficacy and Safety of Suptavumab (REGN2222) for the Prevention of Medically Attended RSV (Respiratory Syncytial Virus) Infection in Preterm Infants | COMPLETED | PHASE3 |
| NCT04605159 | A Phase III, Double-blind Study to Assess Safety and Efficacy of an RSV Maternal Unadjuvanted Vaccine, in Pregnant Women and Infants Born to Vaccinated Mothers | TERMINATED | PHASE3 |
| NCT03979313 | A Study to Evaluate the Safety and Efficacy of MEDI8897 for the Prevention of Medically Attended Lower Respiratory Tract Infection Due to Respiratory Syncytial Virus in Healthy Late Preterm and Term Infants (MELODY) | COMPLETED | PHASE3 |
| NCT05559476 | A Study on the Immune Response and Safety Elicited by a Vaccine Against Respiratory Syncytial Virus (RSV) When Given Alone and Together With a Vaccine Against Influenza in Adults Aged 65 Years and Above | COMPLETED | PHASE3 |
| NCT05238025 | MVA-BN-RSV Vaccine Trial | TERMINATED | PHASE3 |
| NCT06534892 | An Extension and Crossover Vaccination Study on the Immune Response and Safety of a Vaccine Against Respiratory Syncytial Virus Given to Adults 60 Years of Age and Above Who Participated in RSV OA=ADJ-006 Study | ACTIVE_NOT_RECRUITING | PHASE3 |